NEW YORK – Mayo Clinic researchers plan to begin clinical trials of a breast cancer vaccine next year to determine whether it can safely prevent the disease from occurring.
Increasingly, immunotherapies like checkpoint inhibitors and CAR-T cell therapies rely on goading the immune system to attack tumor cells and treat cancer in particular patients, and, at the same time, researchers have been studying whether vaccines could be generated that prevent cancer patients from relapsing by targeting certain features of their disease.